Fred Hutch, Seattle Cancer Care Alliance, and UW Medicine Complete Restructure of Partnership

Learn More

Hutch News

Results per Page: 20
  • 5
  • 10
  • 20
  • 50
  • 100
Cancer, COVID-19 and proceeding with caution

Cancer, COVID-19 and proceeding with caution

Patients in treatment and those with compromised or suppressed immune systems eye the future — and pandemic’s wane — warily
Hutch News - February 16, 2022
Vaccination after CAR-T-cell therapy

Vaccination after CAR-T-cell therapy

From the Hill group, Vaccine and Infectious Disease Division and the UW/Fred Hutch Cancer Consortium
Science Spotlight - December 20, 2021
Diffuse large B cell lymphoma gets new first line therapy

Diffuse large B cell lymphoma gets new first line therapy

From the Gopal laboratory, Clinical Research Division, and the Smith laboratory, University of Washington Medical Oncology
Science Spotlight - March 16, 2020
Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?

Try, try again: Can a 2nd dose of CAR T cells succeed when the first fails?

First-of-its-kind study offers early indication of factors linked to increased odds of success for patients out of options
Hutch News - December 07, 2019
Mariners honor cancer survivor Colin Craig

Mariners honor cancer survivor Colin Craig

Seattle native works to support lifesaving research — like the immunotherapy that put his cancer in remission
Hutch News - May 03, 2018
BCR or biomarker?

BCR or biomarker?

From the Warren laboratory, Clinical Research Division and Vaccine and Infectious Disease Division
Science Spotlight - February 19, 2018
Health disparities may affect end-of-life experiences of minority blood cancer patients

Health disparities may affect end-of-life experiences of minority blood cancer patients

A new study finds ethnic and racial minorities with leukemia or lymphoma are more likely to die in hospital, receive aggressive care in last weeks of life than white patients
Hutch News - December 11, 2017
Mourning the loss of Dr. Oliver 'Ollie' Press

Mourning the loss of Dr. Oliver 'Ollie' Press

Lymphoma physician-scientist, leader and mentor made lifesaving contributions to the development of targeted cancer therapies
Hutch News - October 02, 2017
Last Modified, April 02, 2020